Last reviewed · How we verify
Active CBD
At a glance
| Generic name | Active CBD |
|---|---|
| Also known as | 2000mg/30mL |
| Sponsor | University of Florida |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis (PHASE2)
- Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden (PHASE2)
- Effects of Hemp-Derived Cannabinoids on Menopause Symptoms (PHASE2)
- Home-Based Quadriceps Isometric Exercise for Knee Osteoarthritis Pain (NA)
- Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure (PHASE1)
- Repeated CBD Administration and Cannabis Outcomes (EARLY_PHASE1)
- Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain (PHASE2)
- Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |